vs

Side-by-side financial comparison of Freshworks Inc. (FRSH) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

Freshworks Inc. is the larger business by last-quarter revenue ($222.7M vs $197.9M, roughly 1.1× REPLIGEN CORP). Freshworks Inc. runs the higher net margin — 86.0% vs 6.7%, a 79.2% gap on every dollar of revenue. On growth, Freshworks Inc. posted the faster year-over-year revenue change (14.5% vs 13.6%). Freshworks Inc. produced more free cash flow last quarter ($60.1M vs $17.6M). Over the past eight quarters, Freshworks Inc.'s revenue compounded faster (16.1% CAGR vs 14.4%).

Freshworks Inc. is a cloud-based software-as-a-service company, founded in 2010 in Chennai, India. The company provides cloud-based tools for customer relationship management (CRM), IT service management (ITSM), and e-commerce marketing.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FRSH vs RGEN — Head-to-Head

Bigger by revenue
FRSH
FRSH
1.1× larger
FRSH
$222.7M
$197.9M
RGEN
Growing faster (revenue YoY)
FRSH
FRSH
+0.8% gap
FRSH
14.5%
13.6%
RGEN
Higher net margin
FRSH
FRSH
79.2% more per $
FRSH
86.0%
6.7%
RGEN
More free cash flow
FRSH
FRSH
$42.6M more FCF
FRSH
$60.1M
$17.6M
RGEN
Faster 2-yr revenue CAGR
FRSH
FRSH
Annualised
FRSH
16.1%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRSH
FRSH
RGEN
RGEN
Revenue
$222.7M
$197.9M
Net Profit
$191.4M
$13.3M
Gross Margin
85.6%
52.5%
Operating Margin
17.8%
9.0%
Net Margin
86.0%
6.7%
Revenue YoY
14.5%
13.6%
Net Profit YoY
974.2%
143.9%
EPS (diluted)
$0.66
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRSH
FRSH
RGEN
RGEN
Q4 25
$222.7M
$197.9M
Q3 25
$215.1M
$188.8M
Q2 25
$204.7M
$182.4M
Q1 25
$196.3M
$169.2M
Q4 24
$194.6M
$174.1M
Q3 24
$186.6M
$154.9M
Q2 24
$174.1M
$154.1M
Q1 24
$165.1M
$151.3M
Net Profit
FRSH
FRSH
RGEN
RGEN
Q4 25
$191.4M
$13.3M
Q3 25
$-4.7M
$14.9M
Q2 25
$-1.7M
$14.9M
Q1 25
$-1.3M
$5.8M
Q4 24
$-21.9M
$-30.3M
Q3 24
$-30.0M
$-654.0K
Q2 24
$-20.2M
$3.3M
Q1 24
$-23.3M
$2.1M
Gross Margin
FRSH
FRSH
RGEN
RGEN
Q4 25
85.6%
52.5%
Q3 25
84.7%
53.2%
Q2 25
84.8%
50.0%
Q1 25
84.8%
53.6%
Q4 24
84.9%
26.1%
Q3 24
84.0%
50.0%
Q2 24
83.8%
49.8%
Q1 24
84.3%
49.5%
Operating Margin
FRSH
FRSH
RGEN
RGEN
Q4 25
17.8%
9.0%
Q3 25
-3.5%
8.9%
Q2 25
-4.2%
7.6%
Q1 25
-5.3%
3.9%
Q4 24
-12.2%
-17.7%
Q3 24
-20.8%
-5.1%
Q2 24
-25.1%
1.0%
Q1 24
-19.5%
1.3%
Net Margin
FRSH
FRSH
RGEN
RGEN
Q4 25
86.0%
6.7%
Q3 25
-2.2%
7.9%
Q2 25
-0.8%
8.2%
Q1 25
-0.7%
3.4%
Q4 24
-11.3%
-17.4%
Q3 24
-16.1%
-0.4%
Q2 24
-11.6%
2.2%
Q1 24
-14.1%
1.4%
EPS (diluted)
FRSH
FRSH
RGEN
RGEN
Q4 25
$0.66
$0.24
Q3 25
$-0.02
$0.26
Q2 25
$-0.01
$0.26
Q1 25
$0.00
$0.10
Q4 24
$-0.07
$-0.55
Q3 24
$-0.10
$-0.01
Q2 24
$-0.07
$0.06
Q1 24
$-0.08
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRSH
FRSH
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$781.4M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.0B
$2.1B
Total Assets
$1.6B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRSH
FRSH
RGEN
RGEN
Q4 25
$781.4M
$767.6M
Q3 25
$813.2M
$748.7M
Q2 25
$926.2M
$708.9M
Q1 25
$995.3M
$697.2M
Q4 24
$1.1B
$757.4M
Q3 24
$1.1B
$784.0M
Q2 24
$1.0B
$809.1M
Q1 24
$1.2B
$780.6M
Total Debt
FRSH
FRSH
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FRSH
FRSH
RGEN
RGEN
Q4 25
$1.0B
$2.1B
Q3 25
$851.5M
$2.1B
Q2 25
$984.6M
$2.1B
Q1 25
$1.1B
$2.0B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$2.0B
Q2 24
$1.1B
$2.0B
Q1 24
$1.1B
$2.0B
Total Assets
FRSH
FRSH
RGEN
RGEN
Q4 25
$1.6B
$2.9B
Q3 25
$1.4B
$2.9B
Q2 25
$1.5B
$2.9B
Q1 25
$1.5B
$2.9B
Q4 24
$1.6B
$2.8B
Q3 24
$1.6B
$2.8B
Q2 24
$1.5B
$2.9B
Q1 24
$1.5B
$2.8B
Debt / Equity
FRSH
FRSH
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRSH
FRSH
RGEN
RGEN
Operating Cash FlowLast quarter
$62.3M
$25.7M
Free Cash FlowOCF − Capex
$60.1M
$17.6M
FCF MarginFCF / Revenue
27.0%
8.9%
Capex IntensityCapex / Revenue
1.0%
4.1%
Cash ConversionOCF / Net Profit
0.33×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$236.7M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRSH
FRSH
RGEN
RGEN
Q4 25
$62.3M
$25.7M
Q3 25
$63.5M
$48.1M
Q2 25
$58.6M
$28.6M
Q1 25
$58.0M
$15.0M
Q4 24
$41.4M
$39.2M
Q3 24
$42.3M
$49.3M
Q2 24
$36.3M
$42.2M
Q1 24
$40.6M
$44.7M
Free Cash Flow
FRSH
FRSH
RGEN
RGEN
Q4 25
$60.1M
$17.6M
Q3 25
$61.7M
$43.4M
Q2 25
$58.2M
$21.5M
Q1 25
$56.7M
$11.4M
Q4 24
$36.3M
$33.6M
Q3 24
$41.3M
$42.3M
Q2 24
$34.0M
$37.4M
Q1 24
$39.9M
$36.4M
FCF Margin
FRSH
FRSH
RGEN
RGEN
Q4 25
27.0%
8.9%
Q3 25
28.7%
23.0%
Q2 25
28.4%
11.8%
Q1 25
28.9%
6.8%
Q4 24
18.7%
19.3%
Q3 24
22.1%
27.3%
Q2 24
19.5%
24.3%
Q1 24
24.1%
24.0%
Capex Intensity
FRSH
FRSH
RGEN
RGEN
Q4 25
1.0%
4.1%
Q3 25
0.8%
2.5%
Q2 25
0.2%
3.9%
Q1 25
0.7%
2.1%
Q4 24
2.6%
3.2%
Q3 24
0.6%
4.5%
Q2 24
1.3%
3.1%
Q1 24
0.4%
5.5%
Cash Conversion
FRSH
FRSH
RGEN
RGEN
Q4 25
0.33×
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRSH
FRSH

Subscription Services Software Licenses And Maintenance$220.2M99%
Professional Services$2.5M1%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons